#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrooesophageal cancer Chronic kidney disease Anti-neutrophil cytoplasmic antibody positive vasculitis Liver abscess Epidermolysis bullosa Arginase deficiency Dementia with Lewy bodies Cutaneous T-cell lymphoma stage II Polyneuropathy Mitochondrial DNA depletion Glomerulonephritis membranous Urea cycle disorder Anti-HLA antibody test positive Haematological malignancy Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Basic Information Angelman’s syndrome – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Medulloblastoma recurrent – Treatment Waldenstrom’s macroglobulinaemia – Basic Information Cystic fibrosis lung – Basic Information Rhabdoid tumour – Life with Disease Bronchiolitis obliterans syndrome Hepatoblastoma – Trials in Disease Gaucher’s disease type I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000070248 Oxcarbazepine Marstacimab OLVEREMBATINIB Candesartan Ampreloxetine F125/10 Midostaurin Tapentadol Hydrochloride Mosunetuzumab Warfarin Tabelecleucel RP3 Lerodalcibep LY3841136 SODIUM Bosutinib Mifamurtide Dabrafenib Efmoroctocog Alfa Darbepoetin Alfa More therapies…

    Learn about Your Condition

    Blood disorder Pain Ulcerative keratitis Migraine with aura Post procedural complication Papilloma viral infection Retroperitoneal cancer Hip fracture Overweight Metabolic surgery Gallbladder cancer Hepatorenal syndrome Lymphangioma Renal injury Lichenoid keratosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Post-Surgery Antibiotic Use in Patients with Complicated Acute Appendicitis: Evaluating Metronidazole, Ceftriaxone, and Ofloxacin Hydrochloride

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Ofloxacin Hydrochloride
    • Glucose
    • Ceftriaxone Sodium
    France

  • Study of drug combination with gemcitabine, cisplatin, carboplatin and avelumab in patients with advanced urothelial cancer to evaluate response to platinum-based chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cisplatin
    Italy

  • Study on the Effects of Umeclidinium and Vilanterol in Patients with COPD and Heart Failure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obstructive airways disorder
    Investigated Drugs:
    • Umeclidinium Bromide
    • Vilanterol
    • Fluticasone Propionate
    Spain

  • Study on the Safety and Effectiveness of MSV-allo for Patients with Lupus Nephritis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Msv-Allo
    Spain

  • Chemotherapy Dose Adjustment for Gastrointestinal Cancer Patients with DPD Deficiency Using Fluorouracil, Capecitabine, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    France

  • Study on Atezolizumab and Bevacizumab for Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    France
Previous Page
1 … 426 427 428 429 430 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!